Marcus Horwitz is Distinguished Professor of medicine and of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at the University of California, Los Angeles, US.
Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bioterrorism. Recently, Horwitz and his team has developed a single vector vaccine platform that could offer protection against tularemia, anthrax, plague, and melioidosis – all considered significant bioterrorism threats.
0
min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.